Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. (mở cửa sổ mới)

Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB.

Nguồn‎: Ann Intern Med 2008;148(12):939-55.

Mã bài‎: PubMed 18458272

https://www.ncbi.nlm.nih.gov/pubmed/18458272 (mở cửa sổ mới)

Cost-effectiveness of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. (mở cửa sổ mới)

Moore RD, Charache S, Terrin ML, Barton FB, Ballas SK.

Nguồn‎: Am J Hematol 2000;64(1):26-31.

Mã bài‎: PubMed 10815784

https://www.ncbi.nlm.nih.gov/pubmed/10815784 (mở cửa sổ mới)

Hydroxyurea for the treatment of sickle cell anemia. (mở cửa sổ mới)

Platt OS.

Nguồn‎: N Engl J Med 2008;358(13):1362-9.

Mã bài‎: PubMed 18367739

DOI‎: 10.1056/NEJMct0708272

https://www.ncbi.nlm.nih.gov/pubmed/18367739 (mở cửa sổ mới)

Clinical effectiveness of decitabine in severe sickle cell disease. (mở cửa sổ mới)

Saunthararajah Y, Molokie R, Saraf S, Sidhwani S, Gowhari M, Vara S, Lavelle D, DeSimone J.

Nguồn‎: Br J Haematol 2008;141(1):126-9.

Mã bài‎: PubMed 18324975

DOI‎: 10.1111/j.1365-2141.2008.07027.x

https://www.ncbi.nlm.nih.gov/pubmed/18324975 (mở cửa sổ mới)

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). (mở cửa sổ mới)

Voskaridou E, Christoulas D, Bilalis A, Plata E, Varvagiannis K, Stamatopoulos G, Sinopoulou K, Balassopoulou A, Loukopoulos D, Terpos E.

Nguồn‎: Blood 2010;115(12):2354-63.

Mã bài‎: PubMed 19903897

DOI‎: 10.1182/blood-2009-05-221333

https://www.ncbi.nlm.nih.gov/pubmed/19903897 (mở cửa sổ mới)

Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. (mở cửa sổ mới)

Hirst C, Owusu-Ofori S.

Nguồn‎: Cochrane Database Syst Rev 2012;(9):CD003427.

Mã bài‎: PubMed 22972063

DOI‎: 10.1002/14651858.CD003427.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22972063 (mở cửa sổ mới)

Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial. (mở cửa sổ mới)

Howard J, Ataga KI, Brown RC, Achebe M, Nduba V, El-Beshlawy A, Hassab H, Agodoa I, Tonda M, Gray S, Lehrer-Graiwer J, Vichinsky E

Nguồn‎: Lancet Haematol 2021;8(5):e323-33.

Mã bài‎: PubMed 33838113

DOI‎: 10.1016/S2352-3026(21)00059-4

https://www.ncbi.nlm.nih.gov/pubmed/33838113 (mở cửa sổ mới)

Sickle cell disease. (mở cửa sổ mới)

Meremikwu MM, Okomo U.

Nguồn‎: BMJ Clin Evid 2011;02:2402.

Mã bài‎: PubMed 21718552

https://www.ncbi.nlm.nih.gov/pubmed/21718552 (mở cửa sổ mới)

A phase 3 trial of l-glutamine in sickle cell disease. (mở cửa sổ mới)

Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP

Nguồn‎: N Engl J Med 2018;379(3):226-35.

Mã bài‎: PubMed 30021096

DOI‎: 10.1056/NEJMoa1715971

https://www.ncbi.nlm.nih.gov/pubmed/30021096 (mở cửa sổ mới)

Malaria chemoprophylaxis in sickle cell disease. (mở cửa sổ mới)

Oniyangi O, Omari AA.

Nguồn‎: Cochrane Database Syst Rev 2006;(4):CD003489.

Mã bài‎: PubMed 17054173

DOI‎: 10.1002/14651858.CD003489.pub2

https://www.ncbi.nlm.nih.gov/pubmed/17054173 (mở cửa sổ mới)